We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

177 hedge funds and large institutions have $592M invested in Meridian Bioscience Inc in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 62 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

684% more call options, than puts

Call options by funds: $1.31M | Put options by funds: $167K

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

0% more funds holding

Funds holding: 177 → 177 (0)

3% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 62

4% less capital invested

Capital invested by funds: $615M → $592M (-$22.8M)

Holders
177
Holders Change
–
Holders Change %
0%
% of All Funds
4.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
60
Reduced
62
Closed
16
Calls
$1.31M
Puts
$167K
Net Calls
+$1.14M
Net Calls Change
-$704K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.08M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$4.48M
3
Invesco
Invesco
Georgia
+$4.24M
4
Morgan Stanley
Morgan Stanley
New York
+$2.97M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.63M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.6M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.2M
3
Prudential Financial
Prudential Financial
New Jersey
-$2.05M
4
Deutsche Bank
Deutsche Bank
Germany
-$1.93M
5
CS
Credit Suisse
Switzerland
-$1.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
NSIM
76
North Star Investment Management
Illinois
$789K +$930 +60 +0.1%
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$784K +$29.2K +1,885 +4%
Barclays
78
Barclays
United Kingdom
$757K +$341K +21,973 +76%
State of New Jersey Common Pension Fund D
79
State of New Jersey Common Pension Fund D
New Jersey
$745K – – –
AIMCA
80
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$739K -$547K -35,300 -42%
GIM
81
Greylin Investment Management
Virginia
$709K -$621K -40,050 -46%
Comerica Bank
82
Comerica Bank
Texas
$645K -$55.3K -3,568 -8%
LPIC
83
LeJeune Puetz Investment Counsel
Michigan
$644K -$11.6K -750 -2%
USAA
84
United Services Automobile Association
Texas
$636K -$33.2K -2,140 -5%
State Board of Administration of Florida Retirement System
85
State Board of Administration of Florida Retirement System
Florida
$626K +$10.9K +706 +2%
AIM
86
Assured Investment Management
New York
$625K -$106K -6,842 -14%
AG
87
Aperio Group
California
$609K -$32.5K -2,096 -5%
CS
88
Credit Suisse
Switzerland
$608K -$1.58M -101,606 -71%
VIA
89
Vident Investment Advisory
Georgia
$570K +$169K +10,929 +40%
Two Sigma Investments
90
Two Sigma Investments
New York
$567K -$1.56M -100,458 -73%
SRAM
91
Stone Ridge Asset Management
New York
$562K +$3.1K +200 +0.5%
SLA
92
Silver Lake Advisory
Utah
$550K +$572K +36,909 New
Wellington Management Group
93
Wellington Management Group
Massachusetts
$538K – – –
AIM
94
Alambic Investment Management
California
$534K -$832K -53,643 -60%
Schroder Investment Management Group
95
Schroder Investment Management Group
United Kingdom
$534K -$156K -10,063 -22%
MF
96
Magnetar Financial
Illinois
$512K +$533K +34,351 New
AIG
97
American International Group
New York
$488K +$9.66K +623 +2%
MWAC
98
Mariner Wealth Advisors (Cincinnati)
Ohio
$469K +$1.16K +75 +0.2%
Citigroup
99
Citigroup
New York
$449K -$462K -29,784 -50%
Russell Investments Group
100
Russell Investments Group
United Kingdom
$445K -$787K -50,733 -63%
2 3
4
5 6

VIVO Hedge Fund Activity: Q3 2018 in Review

177 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2018, worth a combined $592M — down 3.7% from $615M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new VIVO positions and 16 closed out — a net gain of 2 holders — while 60 added to existing stakes and 62 trimmed.

The largest buyer was BlackRock, adding an estimated $5.08M. The largest seller was Millennium Management, cutting an estimated $2.6M.

  • 177 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $592M of Meridian Bioscience Inc stock for Q3 2018, down 3.7% quarter-over-quarter.
  • 18 funds opened new Meridian Bioscience Inc positions in Q3 2018 and 16 closed out, a net change of +2 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2018 was BlackRock, an estimated $5.08M added.
  • The largest Meridian Bioscience Inc seller in Q3 2018 was Millennium Management, an estimated $2.6M sold.

Based on aggregated 13F filings for Q3 2018.